ProKidney's stock price showed promise after a business combination with a SPAC, but suffered a major downward correction last year.The company's lead product candidate, rilparencel, is a personalized...
Source LinkProKidney's stock price showed promise after a business combination with a SPAC, but suffered a major downward correction last year.The company's lead product candidate, rilparencel, is a personalized...
Source Link
Comments